Effect of reperfusion modality on outcome in nonsmokers and smokers with acute myocardial infarction (A primary angioplasty in myocardial infarction [PAMI] substudy)

American Journal of Cardiology

Volumn 78, Issue 5, 1996, Pages 511-515

  Bowers, Terry R ^a   Terrien, Edward F ^a   O'Neill, William W ^a   Sachs, Debra ^a   Grines, Cindy L ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SMOKING; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLASMINOGEN ACTIVATORS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SMOKING; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 0030237966     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00354-2     Document Type: Article

References (28)

1. Fitzgerald GA, Oates JA, Nowak J. Cigarette smoking and hemostatic function. Am Heart J 1988;15:267-271.
2. Fuster V, Chesebro JH, Frye RL, Elveback LR. Platelet survival and the development of coronary artery disease in the young adult: effect of cigarette smoking, strong family history and medical therapy. Circulation 1981;63:546-551.
3. Barbash GI, White HD, Modan M, Diaz R, Hampton JR, Heikkila J, Kristinsson A, Moulopoulos S, Paolasso EAC, Van der Werf T, Pehrsson K, Sandoe E, Simes J, Wilcox RG, Verstraete M, von der Lippe G, Van der Werf F, for the Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Circulation 1993;87:53-58.
4. Garrison RJ, Kannel WB, Feinlieb M, Castelli WP, McNamera S. Cigarette smoking and HDL cholesterol. The Framingham offspring study. Atherosclerosis 1978;30:17-251.
5. Ramsdale DR, Faragher EB, Bray CL, Bennett DH, Ward C, Beton DC. Smoking and coronary artery disease assessed by routine coronary angiography. Br Med J 1985;290:197-200.
6. Doll R, Peto R. Mortality in relation to smoking : twenty years' observations of male British doctors. Br Med J 1976;2:1525-1536.
7. Wilhelmsen L. Coronary heart disease: epidemiology of smoking and intervention studies of smoking. Am Heart J 1988;115:242-249.
8. LaCroix AZ, Lang J, Scherr P, Wallace RB, Cornoni-Huntley J, Berkman L, Curb D, Evans D, Hennekens CH. Smoking and mortality among older men and women in three communities. N Engl J Med 1991;324:1619-1625.
9. AIMS Trial Study Group. Long-term effects of intravenous anistreplase in acute myocardial infarction: final report of the AIMS study. Lancet 1990;335:427-431.
10. Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico. GISSI-2. A factorial randomized trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with myocardial infarction. Lancet 1990;336:65-71.
11. Mueller HS, Cohen LS, Braunwald E, Forman S, Feit F, Ross A, Schweiger M, Cabin H, Davison R, Miller D, Solomon R, Knatterud GL, for the TIMI Investigators. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction: analysis of patient subgroups in the TIMI trial, phase II. Circulation 1992;85:1254-1264.
12. Grines CL, Topol EJ, O'Neill WW, George BS, Kereiakes D, Phillips HR, Leimberger JD, Woodlief LH, Califf RM, for the TAMI Investigators. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation 1995;91:298-303.
13. Barbash GI, Reiner JS, Granger CB, White HD, Lundergan CF, Ross AM, for the GUSTO Investigators. Smoking and acute myocardial infarction sur-vival: demographic and quantitative angiographic foundations for the "smoker's paradox" (abstr). Circulation 1994;90:221.
14. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J, Overlie P, Donohue B, Chelliah N, Timmis GC, Vlietstra RE, Strzelecki M, Puchrowicz-Ochrocki S, O'Neill WW, for the Primary Angioplasty in Myocardial Infarction Study Group. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673-679.
15. Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfensperger MR, Gersh BJ. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 1993;328:685-691.
16. Sparrow D, Dawber TR, Colton T. Influence of cigarette smoking on prognosis after a first myocardial infarction. J Chronic Dis 1978;31:425-432.
17. O'Neill WW, Brodie B, Knopf W, Ivanhoe R, O'Keefe J, Taylor G, Berdan L, Woodlief L, Califf R, Duke Medical Center, Durham, NC. Initial report of the Primary Angioplasty Revascularization (PAR) Multicenter Registry (abstr). Circulation 1991;84(suppl 2):II-536.
18. O'Keefe J, Rutherford BD, McConahay DR, Ligon RW, Johnson WL Jr, Giorgi LV, Crockett JE, McCallister BD, Conn RD, Gura GM, Good TH, Steinhaus DM, Bateman TM, Shimshak TM, Hartzler GO. Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1989;64:1221-1230.
19. Vlietstra RE, Kronmal RA, Frye RL, Seth AK, Tristani FE, Killip T III. Factors affecting the extent and severity of coronary heart disease in patients enrolled in the Coronary Artery Surgery Study. Atherosclerosis 1982;2:208-215.
20. Laster SB, O'Keefe J, Gibbons RJ. The incidence and importance of TIMI 3 flow following primary infarct angioplasty (abstr). Circulation 1994;90:I-221.
21. O'Neill WW, Timmis GC, Bourdillon PD, Lai P, Ganghadarhan V, Walton J, Ramos R, Laufer N, Gordon S, Schork A, Pitt B. A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction. N Engl J Med 1986;314:812-818.
22. Zijlstra F, de Boer MJ, Hoorntje JCA, Reiffers S, Reiber JHC, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328:680-684.
23. Dittrich H, Gilpin E, Nicod P, Cali G, Henning H, Ross J Jr. Acute myocardial infarction in women: influence of gender on mortality and prognostic variables. Am J Cardiol 1988;62:1-7.
24. Weisfeldt ML, Lakatta EG, Gerstenblith G. Aging and the heart. In: Braunwald, ed. Heart Disease, a Textbook of Cardiovascular Medicine. 4th ed. 1992:1656-1666.
25. Zahger D, Cercek B, Cannon CP, Jordan M, Davis V, Braunwald E, Shah PK, for the TIMI-4 Investigators. How do smokers differ from nonsmokers in their response to thrombolysis? (The TIMI-4 Trial.) Am J Cardiol 1995;75:232-236.
26. How does smoking harm the heart? [editorial] Br Med J 1980;281:573-574.
27. Gomez MA, Karagounis LA, Allen A, Anderson JL, for the TEAM-2 Investigators. Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction. Am J Cardiol 1993;72:373-378.
28. Nyboe J, Jensen G, Appleyard M, Schnohr P. Smoking and the risk of first acute myocardial infarction. Am Heart J 1991;122:438-444.